Czernichow, Sébastien
Renuy, Adeline
Rives-Lange, Claire
Carette, Claire
Airagnes, Guillaume
Wiernik, Emmanuel
Ozguler, Anna
Kab, Sofiane
Goldberg, Marcel
Zins, Marie
Matta, Joane
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-11-INBS0002, ANR-11-INBS0002)
Article History
Received: 4 February 2021
Accepted: 16 June 2021
First Online: 8 July 2021
Competing interests
: Sébastien Czernichow has received honoraria from Novo Nordisk, Sanofi, Lilly, Janssen, Servier, Novartis, fitforme, BMS and Fresenius outside the present work. He owns shares of Mygoodlife and serves as a member of the scientific advisory board of Bariatek. Claire Carette has received honoraria from Astra Zeneca, Lilly, Novo Nordisk, Novartis Pharma, MSD France, IPSEN Pharma, Pfizer, Publicis Health outside the presented work. Guillaume Airagnes has received speaker and/or consulting fees from Pierre Fabre, Lundbeck, Pfizer and MasterClass Santé. Claire Rives Lange reports personal fees from Nestlé Health Sciences and Fitforme. The other authors have nothing to declare.